Individualizatsiya terapii tsentral'nogo nesakharnogo diabeta: klinicheskiy sluchay primeneniya preparata «Presayneks»
https://doi.org/10.14341/2071-8713-4983
Abstract
Central diabetes insipidus (CDI) - a severe disease with disturbance of arginine vasopressin secretion, with excretion of large
amounts of hypotonic urine, which leads to dehydration and thirst. Desmopressin, a synthetic analog of arginine vasopressin, is used to
compensate a water-electrolyte balance in patients with CDI is available in forms of intranasal spray and tablets. Herein we present a
clinical case of a patient with longstanding CDI due to Langerhans cell hystiocytosis in childhood who received different medications
for treatment of CDI symptoms that demonstrates variable efficiency and tolerance of these drugs.
amounts of hypotonic urine, which leads to dehydration and thirst. Desmopressin, a synthetic analog of arginine vasopressin, is used to
compensate a water-electrolyte balance in patients with CDI is available in forms of intranasal spray and tablets. Herein we present a
clinical case of a patient with longstanding CDI due to Langerhans cell hystiocytosis in childhood who received different medications
for treatment of CDI symptoms that demonstrates variable efficiency and tolerance of these drugs.
References
1. Goodfriend T.L., Friedman A.L., Shenker Y. Hormonal regulation of electrolyte and water metabolism // Endocrinology, 5th Edition. Edited by DeGroot L.J. and Jameson J.L. Chapter 133, 2006.
2. Дзеранова Л.К., Пигарова Е.А. Несахарный диабет. Эндокринология: национальное руководство под ред. И.И. Дедова, Г.А. Мельниченко. - ГЭО- ТАР-Медиа, 2008. - C. 673-677.
3. Дзеранова Л.К., Пигарова Е.А. Центральный несахарный диабет: современные аспекты диагностики и лечения. Лечащий врач, 2006, 10: C. 42-47.
4. Пигарова Е.А. Центральный несахарный диабет: патогенетические и прогностические аспекты, дифференциальная диагностика. Диссертация ... к.м.н. М: 2009, 203 с.
Review
For citations:
, , Individualizatsiya terapii tsentral'nogo nesakharnogo diabeta: klinicheskiy sluchay primeneniya preparata «Presayneks». Obesity and metabolism. 2010;7(3):39-41. (In Russ.) https://doi.org/10.14341/2071-8713-4983
Views:
370
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
